Described herein are anti MCAM antibodies and antigen binding fragments thereof that are capable of inhibiting the interaction between MCAM and its ligand a protein comprising a laminin a 4 chain. These anti MCAM antibodies and antigen binding fragments thereof may be useful for for example treating inflammatory conditions characterized by the infiltration of MCAM expressing cells into a site of inflammation in the body.